OpenVSafe by OpenVAERS
Search V-safe

2Q2-23761-72505

3 vaccinations 8 coded responses 11 check-ins 8 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
481 / MI
Registered
2021-12-04
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-17
    Dose 1 — Pfizer-BioNTech
  2. 2021-05-06
    Dose 2 — Pfizer-BioNTech
  3. 2021-12-02
    Dose 3 — Moderna
  4. 2021-12-04
    Registered in v-safe
  5. 2021-12-05
    Survey response — days 1–6 daily, dose 3
    MedDRA: Swelling of eyelid — Feeling: Poor · Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Free text: Swollen eyelid for the past 3 days
    MedDRA releases: 2024-11 · check-in free text available
  6. 2021-12-06
    Survey response — days 1–6 daily, dose 3
    MedDRA: Rash, Swelling of eyelid, Urticaria — Feeling: Poor · Site: Pain · Headache, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Free text: Swollen eyelid that appeared on Friday, 24 hours after receiving booster and at same time as rash and hives on my hands
    MedDRA releases: 2024-11 · check-in free text available
  7. 2021-12-07
    Survey response — days 1–6 daily, dose 3
    MedDRA: Swelling of eyelid — Feeling: Fair · Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Free text: Swollen eyelid
    MedDRA releases: 2024-11 · check-in free text available
  8. 2021-12-08
    Survey response — days 1–6 daily, dose 3
    MedDRA: Swelling of eyelid — Feeling: Good · Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Free text: Eyelid swelling
    MedDRA releases: 2024-11 · check-in free text available
  9. 2021-12-09
    Survey response — day 7, dose 3
    MedDRA: Swelling of eyelid — Feeling: Fair · Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Free text: Eyelid swelling
    MedDRA releases: 2024-11 · check-in free text available
  10. 2021-12-17
    Survey response — day 14, dose 3
    MedDRA: Dysmenorrhoea, Menstrual disorder, Menstrual headache, Nausea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: My menstrual cycle started and the symptoms are significantly elevated compared to normal. Very sick to my stomach, nausea, body aches, cramps, headache for days leading up to, beyond what is typical
    MedDRA releases: 2024-11 · check-in free text available
  11. 2021-12-25
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  12. 2022-01-08
    Survey response — day 35, dose 3
    MedDRA: Swelling of eyelid, Urticaria — Feeling: Good
    Free text: Swollen eyelid, hives returned 10 days ago
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-01-13
    Survey response — day 42, dose 3
    MedDRA: Cough, Exposure to SARS-CoV-2, Headache, Nausea, Oropharyngeal pain, SARS-CoV-2 test — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Headache for multiple days, nauseous, sore throat, dry cough. Exposed to Covid on Thursday, awaiting results of PCR
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-01-13
    Report sent to call center — day 42, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  15. 2022-01-18
  16. 2022-03-05
    Health check-in — 3 months, dose 3
    Feeling: Fair
    Adult check-in
  17. 2022-12-02
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-17Pfizer-BioNTech No
22021-05-06Pfizer-BioNTech No
32021-12-02Moderna No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 10 — days 1–6 daily, dose 3

2021-12-05

Systemic reaction (other): Swollen eyelid for the past 3 days

2021-12-06

Systemic reaction (other): Swollen eyelid that appeared on Friday, 24 hours after receiving booster and at same time as rash and hives on my hands

2021-12-07

Systemic reaction (other): Swollen eyelid

2021-12-08

Systemic reaction (other): Eyelid swelling

Release 10 — day 7, dose 3

2021-12-09

Systemic reaction (other): Eyelid swelling

Release 10 — day 14, dose 3

2021-12-17

Symptoms: My menstrual cycle started and the symptoms are significantly elevated compared to normal. Very sick to my stomach, nausea, body aches, cramps, headache for days leading up to, beyond what is typical

Release 10 — day 35, dose 3

2022-01-08

Symptoms: Swollen eyelid, hives returned 10 days ago

Release 10 — day 42, dose 3

2022-01-13

Symptoms: Headache for multiple days, nauseous, sore throat, dry cough. Exposed to Covid on Thursday, awaiting results of PCR

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDDysmenorrhoea · · ✓
SDExposure to SARS-CoV-2 · · ✓
SDHeadache · · ✓
SDMenstrual disorder · · ✓
SDMenstrual headache · · ✓
SDNausea · · ✓
SDOropharyngeal pain · · ✓
SDSARS-CoV-2 test · · ✓
SDSwelling of eyelid · · ✓
SDUrticaria · · ✓
SRORash · · ✓
SROSwelling of eyelid · · ✓
SROUrticaria · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release